$PRCT
PROCEPT BioRobotics Corp Stock $prct

$prct Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000158897822000005 Filed on November 04, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$23.78M	$20.35M
YoY Change	134.53%	134.76%
Cost Of Revenue	$13.10M	$10.12M
YoY Change	133.03%	128.5%
Gross Profit	$10.68M	$10.23M
YoY Change	136.4%	141.3%
Gross Profit Margin	44.9%	50.28%
Selling, General & Admin	$26.03M	$24.75M
YoY Change	60.0%	104.27%
% of Gross Profit	243.86%	241.95%
Research & Development	$9.682M	$7.582M
YoY Change	90.74%	54.14%
% of Gross Profit	90.69%	74.11%
Depreciation & Amortization	$663.0K	$703.0K
YoY Change	-13.11%	-11.68%
% of Gross Profit	6.21%	6.87%
Operating Expenses	$35.72M	$32.34M
YoY Change	67.31%	89.8%
Operating Profit	-$25.04M	-$22.11M
YoY Change	48.77%	72.74%
Interest Expense	$126.0K	$1.455M
YoY Change	-108.38%	-0.95%
% of Operating Profit
Other Income/Expense, Net	$0.00
YoY Change	-100.0%
Pretax Income	-$28.17M	-$22.61M
YoY Change	53.54%	60.34%
Income Tax
% Of Pretax Income
Net Earnings	-$28.17M	-$22.61M
YoY Change	53.54%	60.34%
Net Earnings / Revenue	-118.48%	-111.13%
Basic Earnings Per Share		-$0.51
Diluted Earnings Per Share	-$0.63	-$0.51
COMMON SHARES
Basic Shares Outstanding	44.72M shares	44.59M shares
Diluted Shares Outstanding		44.64M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$221.9M	$249.2M
YoY Change	-27.1%	-22.24%
Cash & Equivalents	$221.9M	$249.2M
Short-Term Investments
Other Short-Term Assets	$6.952M	$4.519M
YoY Change	103.75%	135.12%
Inventory	$28.54M	$22.36M
Prepaid Expenses
Receivables	$15.27M	$12.84M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$272.6M	$288.9M
YoY Change	-16.42%	-14.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.656M	$5.120M
YoY Change	71.58%	-10.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$51.00K	$202.0K
YoY Change		-74.0%
Total Long-Term Assets	$36.70M	$35.11M
YoY Change	238.25%	192.71%
TOTAL ASSETS
Total Short-Term Assets	$272.6M	$288.9M
Total Long-Term Assets	$36.70M	$35.11M
Total Assets	$309.3M	$324.0M
YoY Change	-8.22%	-7.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.391M	$6.331M
YoY Change	362.84%	76.35%
Accrued Expenses	$20.68M	$12.76M
YoY Change	84.58%	50.22%
Deferred Revenue	$2.855M	$2.342M
YoY Change	178.54%	176.18%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$35.29M	$27.36M
YoY Change	117.28%	92.95%
LONG-TERM LIABILITIES
Long-Term Debt	$51.21M	$50.69M
YoY Change	2.42%	1.87%
Other Long-Term Liabilities	$0.00	$200.0K
YoY Change	-100.0%	0.0%
Total Long-Term Liabilities	$51.21M	$50.89M
YoY Change	2.01%	1.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.29M	$27.36M
Total Long-Term Liabilities	$51.21M	$50.89M
Total Liabilities	$112.3M	$103.3M
YoY Change	60.52%	51.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$348.7M	-$320.5M
YoY Change	33.34%	31.78%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$197.1M	$220.8M
YoY Change
Total Liabilities & Shareholders Equity	$309.3M	$324.0M
YoY Change	-8.22%	-7.8%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$28.17M	-$22.61M
YoY Change	53.54%	60.34%
Depreciation, Depletion And Amortization	$663.0K	$703.0K
YoY Change	-13.11%	-11.68%
Cash From Operating Activities	-$25.17M	-$19.85M
YoY Change	52.79%	55.68%
INVESTING ACTIVITIES
Capital Expenditures	$866.0K	-$1.514M
YoY Change	-360.84%	1263.96%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$866.0K	-$1.514M
YoY Change	160.84%	1263.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.318M	777.0K
YoY Change	-304.66%	-99.55%
NET CHANGE
Cash From Operating Activities	-25.17M	-19.85M
Cash From Investing Activities	-866.0K	-1.514M
Cash From Financing Activities	-1.318M	777.0K
Net Change In Cash	-27.36M	-20.59M
YoY Change	69.25%	-112.77%
FREE CASH FLOW
Cash From Operating Activities	-$25.17M	-$19.85M
Capital Expenditures	$866.0K	-$1.514M
Free Cash Flow	-$26.04M	-$18.34M
YoY Change	61.3%	45.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001588978
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Entity Registrant Name EntityRegistrantName	PROCEPT BioRobotics Corporation
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40797
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0199180
	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Island Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94065
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	232-7200
	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value per share
	dei	Trading Symbol TradingSymbol	PRCT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44720047	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	249217000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	304320000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12838000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4464000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	22358000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	13147000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4519000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4242000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	288932000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	326173000	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3814000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	777000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5120000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5045000	usd
CY2021Q1	prct	Line Of Credit Facility Gain Loss On Amendment Of Debt Terms LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms	0	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24424000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3279000	usd
CY2022Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1545000	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1750000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	202000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2022Q3	us-gaap	Assets Assets	324037000	usd
CY2021Q4	us-gaap	Assets Assets	337024000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6331000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2029000	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	10284000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6475000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2342000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1025000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2473000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2105000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5929000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4608000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	27359000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16242000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50692000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50004000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23415000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1991000	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1609000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1496000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	103275000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	69933000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44714000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44714000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43676000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43676000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	541048000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	528666000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	217000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-54000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320503000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-261521000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	220762000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	324037000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	337024000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20349000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8668000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51237000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24335000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	10118000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	4428000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	24828000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	12986000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	10231000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	4240000	usd
	us-gaap	Gross Profit GrossProfit	26409000	usd
	us-gaap	Gross Profit GrossProfit	11349000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7582000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4919000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19299000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13917000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24754000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12118000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62794000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34765000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	32336000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	17037000	usd
	us-gaap	Operating Expenses OperatingExpenses	82093000	usd
	us-gaap	Operating Expenses OperatingExpenses	48682000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-22105000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12797000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-55684000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37333000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1455000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	1469000	usd
	us-gaap	Interest Expense InterestExpense	4317000	usd
	us-gaap	Interest Expense InterestExpense	4370000	usd
CY2022Q3	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	947000	usd
CY2021Q3	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	163000	usd
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	1019000	usd
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	198000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-22613000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14103000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58982000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41505000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.64
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44640000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44640000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11580000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11580000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44276000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44276000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7361000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7361000	shares
CY2022Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	185000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-2000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	271000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-27000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22428000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14105000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58711000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41532000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1291000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1552000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	252750000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1572000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1289000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	2676000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	85000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-19184000	usd
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	239188000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	777000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	3225000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	185000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-22613000	usd
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	220762000	usd
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-182894000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1225000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	650000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-16000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	usd
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-193857000	usd
CY2021Q2	prct	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	4448000	shares
CY2021Q2	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	84710000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1415000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	725000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-9000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14580000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	29850000	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	328564000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-206306000	usd
CY2021Q3	prct	Temporary Equity Stock Issued During Period Shares Warrant Exercises TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises	62000	shares
CY2021Q3	prct	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	970000	usd
CY2021Q3	prct	Temporary Equity Shares Conversion Of Convertible Securities TemporaryEquitySharesConversionOfConvertibleSecurities	29912000	shares
CY2021Q3	prct	Temporary Equity Amount Conversion Of Convertible Securities TemporaryEquityAmountConversionOfConvertibleSecurities	329534000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	329534000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	172409000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	855000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	925000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14103000	usd
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	283312000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58982000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41505000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2178000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2561000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7452000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2300000	usd
	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	113000	usd
	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	-235000	usd
	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	-645000	usd
	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	249000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	87000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	537000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8375000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4804000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9502000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3580000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	606000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	202000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4243000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2362000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	3810000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	235000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	688000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	804000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1318000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	615000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1321000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	707000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55208000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40858000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1787000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	260000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1787000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-260000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	84710000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1289000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3641000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3495000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	858000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	172409000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4930000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	261472000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52065000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	220354000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	305096000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100907000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	253031000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321261000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	249217000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	320484000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3814000	usd
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	777000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	253031000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321261000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3573000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3566000	usd
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	203000	usd
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	-1227000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	200000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	200000	usd
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	819000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22668000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	249200000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320500000	usd
	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company’s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2021Q3	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	13200000	usd
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2900000	usd
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1890000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	11757000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6740000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	905000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8711000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5502000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	22358000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	13147000	usd
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2500000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	800000	usd
CY2021Q4	prct	Finite Lived Intangible Asset Expected Annual Amortization Expense FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense	300000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3225000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	925000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7452000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2300000	usd
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-22613000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14103000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58982000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41505000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44640000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44640000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11580000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11580000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44276000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44276000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7361000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7361000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.64
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	658000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6114000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6607000	shares
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20349000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8668000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51237000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24335000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5610000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1900000	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	3300000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1500000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	658000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	12500000	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	18110000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4184000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	37500000	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	41684000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4297000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Three OperatingLeaseLiabilityAndLongTermDebtMaturityYearThree	4297000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4426000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Four OperatingLeaseLiabilityAndLongTermDebtMaturityYearFour	4426000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	24146000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Thereafter OperatingLeaseLiabilityAndLongTermDebtMaturityThereafter	24146000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	43321000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	93321000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17433000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	692000	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	16741000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	25888000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	50692000	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	76580000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2473000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	2473000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23415000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50692000	usd
CY2022Q3	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	74107000	usd

Files In Submission

Name	View Source	Status
0001588978-22-000005-index-headers.html	Edgar Link	pending
0001588978-22-000005-index.html	Edgar Link	pending
0001588978-22-000005.txt	Edgar Link	pending
0001588978-22-000005-xbrl.zip	Edgar Link	pending
ex311soxcertificationrzadn.htm	Edgar Link	pending
ex312soxcertificationkwate.htm	Edgar Link	pending
ex321soxcertificationrzadn.htm	Edgar Link	pending
ex322soxcertificationkwate.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prct-20220930.htm	Edgar Link	pending
prct-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
prct-20220930_cal.xml	Edgar Link	unprocessable
prct-20220930_def.xml	Edgar Link	unprocessable
prct-20220930_lab.xml	Edgar Link	unprocessable
prct-20220930_pre.xml	Edgar Link	unprocessable
prct-20220930_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRCT
PROCEPT BioRobotics Corp Stock $prct

2022 Q4 Form 10-Q Financial Statement

#000158897822000005 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT PROCEPT BioRobotics Corp Stock $prct

2022 Q4 Form 10-Q Financial Statement

#000158897822000005 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT
PROCEPT BioRobotics Corp Stock $prct